Corticosteroid Therapy Guidelines

Administration and Dosage

The American Academy of Pediatrics recommends a single daily dose for most conditions, with an initial episode dose of 60 mg/m² per day (maximum 60 mg) for 6 weeks, followed by 40 mg/m² as a single morning dose on alternate days for 6 weeks, and then tapering at a rate of 10 mg/m² per week to 5 mg on alternate days (total duration 16 weeks) 1
For relapse treatment, a dose of 60 mg/m² (maximum 60 mg/day) daily until remission for at least 3 consecutive days is recommended 1
The maximum dose for children is generally capped at 60 mg/day, as recommended by the American Academy of Pediatrics 2
For significantly overweight patients, dosing should be based on ideal body weight rather than actual weight to minimize adverse effects, as suggested by relevant medical guidelines, including the American Journal of Kidney Diseases 2, 3
The American Academy of Allergy, Asthma, and Immunology recommends a maximum dose of 60 mg/day or 2 mg/kg/day (whichever is lower) for children, and 40-60 mg/day as a single or divided dose for 3-10 days for adults with asthma exacerbations, with a strength of evidence based on clinical guidelines 3

The following condition-specific doses are recommended:
| Condition | Recommended Dose | | --- | --- | | Autoimmune hepatitis | 40 mg daily or 0.6-0.8 mg/kg daily for the first 4 weeks 4 | | Bullous pemphigoid | 0.75-1 mg/kg (41-55 mg/day) for severe cases, 0.5 mg/kg (27.5 mg/day) for moderate cases, and 0.3 mg/kg (16.5 mg/day) for mild cases 5 | | Duchenne muscular dystrophy | 0.75 mg/kg/day (41.25 mg/day) is more effective than 0.3 mg/kg/day, with the minimum effective dose being 0.3 mg/kg/day (16.5 mg/day) 6 | | Alcoholic hepatitis | 40 mg/day for 28 days, then tapered 7 | | Nephrotic syndrome | 2 mg/kg/day (maximum 60 mg/day) 2, 8 | | Dermatitis/rash | 0.5-1 mg/kg/day tapered over 2 weeks 9 | | Colitis | 1-2 mg/kg/day, tapered over 4-6 weeks when improved 9 | | Asthma exacerbation | 1-2 mg/kg/day (maximum 60 mg) for 3-10 days, with no advantage of IV or IM preparations over oral route if gastrointestinal absorption is not impaired, as suggested by the American Academy of Pediatrics 10, 3
For nephrotic syndrome, the total treatment duration is 16 weeks for the initial episode 1

Monitoring should include blood pressure, glucose levels, bone density, signs of infection, mood changes, and sleep disturbances, as recommended by the British Journal of Dermatology 5, 6
Tapering after disease control typically involves reducing the dose by one-third or one-quarter down to 15 mg daily, then by 2.5 mg decrements to 10 mg daily, then by 1 mg monthly, as suggested by the British Journal of Dermatology 5
Condition-specific tapering schedules include:

The American Academy of Otolaryngology-Head and Neck Surgery lists contraindications for corticosteroid use, including active untreated infections, patients already receiving exogenous steroids, and patients with endocrine disorders where steroid administration may interfere with glucose-insulin regulation 14
Corticosteroid therapy is recommended with caution in patients with pre-existing conditions such as diabetes, hypertension, glaucoma, or psychiatric disorders, as recommended by the American Academy of Allergy, Asthma, and Immunology 9
During pregnancy, prednisone should be used with caution, considering risks and benefits, as advised by obstetrical societies 15
Use with caution in patients with active infections, and live vaccines should be avoided during treatment, as recommended by the Infectious Diseases Society of America and the Centers for Disease Control and Prevention 9
Consider prophylaxis against Pneumocystis jirovecii in patients on higher doses, as recommended by the European League Against Rheumatism 16